Xiaoqun Qin Selected Research

Xiaoqun Qin Research Topics

Disease

24	Asthma (Bronchial Asthma) 04/2024 - 08/2010
13	Inflammation (Inflammations) 01/2024 - 01/2007
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 11/2019
3	Wounds and Injuries (Trauma) 01/2020 - 08/2010
2	Lung Injury 01/2023 - 11/2022
2	Airway Remodeling 01/2023 - 12/2019
2	Pneumonia (Pneumonitis) 01/2023 - 01/2018
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2022 - 11/2022
2	Neoplasms (Cancer) 01/2022 - 06/2016
2	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 01/2020
2	Respiratory Syncytial Virus Infections 11/2020 - 01/2014
2	Respiratory Hypersensitivity 01/2018 - 01/2013
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2024
1	Communicable Diseases (Infectious Diseases) 09/2022
1	Hyperplasia 01/2022
1	Respiratory Tract Diseases (Respiratory Tract Disease) 11/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Neuroinflammatory Diseases 01/2019
1	Allergic Rhinitis 01/2019
1	Mania (Manias) 08/2018
1	Shock 09/2016
1	Breast Neoplasms (Breast Cancer) 06/2016
1	Obesity 01/2012
1	Hypertension (High Blood Pressure) 01/2012
1	Persistent Infection 12/2008

Drug/Important Bio-Agent (IBA)

9	IntegrinsIBA 09/2022 - 01/2012
5	alpha Catenin (alpha E-Catenin)IBA 04/2024 - 01/2018
5	CytokinesIBA 01/2024 - 01/2013
5	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2014
4	Biomarkers (Surrogate Marker)IBA 03/2021 - 11/2019
3	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 12/2019
3	Interleukin-4 (Interleukin 4)IBA 01/2022 - 01/2013
3	AllergensIBA 11/2021 - 01/2018
2	OzoneIBA 04/2024 - 01/2007
2	Bombesin Receptors (Bombesin Receptor)IBA 01/2024 - 11/2022
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 01/2023
2	Messenger RNA (mRNA)IBA 01/2021 - 11/2019
2	Chloride Channels (Chloride Channel)IBA 01/2021 - 01/2020
2	NeuropeptidesIBA 01/2019 - 01/2007
2	apelin-13 peptideIBA 01/2019 - 09/2016
2	bombesin receptor subtype 3IBA 01/2018 - 01/2012
2	Calcitonin Gene-Related PeptideIBA 12/2008 - 01/2007
1	Imiquimod (Aldara)FDA LinkGeneric 01/2024
1	GlucocorticoidsIBA 01/2023
1	DNA Glycosylases (DNA Glycosylase)IBA 01/2023
1	JNK Mitogen-Activated Protein KinasesIBA 01/2023
1	Toll-Like Receptor 4IBA 01/2023
1	8-hydroxyguanineIBA 01/2023
1	Protein Tyrosine PhosphatasesIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2023
1	Bleomycin (Blenoxane)FDA LinkGeneric 11/2022
1	Circulating Tumor DNAIBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	ParaffinIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	human ERBB2 proteinIBA 01/2021
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2021
1	BombesinIBA 01/2021
1	ChloridesIBA 01/2021
1	Decitabine FDA Link 12/2020
1	MicroRNAs (MicroRNA)IBA 11/2020
1	Anoctamin-1IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 12/2019
1	Oxidants (Oxidizing Agents)IBA 12/2019
1	hydrogen sulfite (bisulfite)IBA 11/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019
1	Streptozocin (Streptozotocin)FDA Link 01/2019
1	Interleukin-13IBA 08/2018
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 08/2018
1	Thymic Stromal LymphopoietinIBA 01/2018
1	ChemokinesIBA 01/2018
1	UbiquitinIBA 01/2014
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2014
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 09/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2013
1	Interleukin-17 (Interleukin 17)IBA 01/2013
1	Small Interfering RNA (siRNA)IBA 08/2010
1	Integrin beta4IBA 08/2010
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 12/2008
1	Substance PIBA 12/2008
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2007

Therapy/Procedure

1	Therapeutics 01/2019